Patient Factors Influencing Dermal Filler Complications: Prevention, Assessment, and Treatment

Document Type : Systematic Review

Authors

1 Trauma and Injury Research Center, Iran University of Medical Sciences, Tehran, Iran phd of Anatomy, Student Research Committee, Iran University of Medical Sciences, Tehran, Iran

2 General Practitioner (MD(, Restorative Cosmetic Doctor, Private Practice, Tehran, Iran

Abstract
Dermal fillers are widely used in aesthetic medicine for facial rejuvenation and volume restoration. Although generally considered safe, complications—ranging from mild to severe—can occur. Patient-related factors significantly contribute to the risk, nature, and severity of these adverse effects. This review explores how age, medical history, skin type, lifestyle habits (such as smoking and sun exposure), and immune status influence the development of dermal filler complications. Inadequate patient selection and insufficient pre-treatment assessment can lead to undesirable outcomes including granuloma formation, delayed hypersensitivity reactions, and vascular compromise. Moreover, psychological factors and unrealistic expectations may complicate the therapeutic course. Prevention begins with thorough patient evaluation, informed consent, and individualized treatment planning. In the event of complications, early recognition and a tailored treatment strategy—ranging from conservative management to enzymatic or surgical intervention—are crucial. Understanding patient-specific risks not only enhances safety but also optimizes outcomes. This article aims to guide clinicians in integrating patient factors into the prevention, assessment, and treatment of dermal filler complications, ultimately contributing to safer and more effective aesthetic practices.

Graphical Abstract

Patient Factors Influencing Dermal Filler Complications: Prevention, Assessment, and Treatment

Keywords

Subjects

Introduction

Dermal fillers, primarily composed of hyaluronic acid, calcium hydroxylapatite, and Poly-L-lactic acid, are widely used in cosmetic dermatology [1]. With the growing popularity of aesthetic procedures, filler injections have become one of the most commonly performed non-surgical interventions globally. Despite their general safety, fillers are not without risks [2]. While product-related factors and technique are important, patient-specific factors play a significant role in influencing the likelihood and type of complications that may arise [3]. Understanding these patient-centered risks is essential for clinicians aiming to ensure optimal outcomes and patient satisfaction [4]. Dermal fillers have become an integral component of modern aesthetic medicine, offering minimally invasive, effective, and versatile options for facial rejuvenation, contouring, and volume restoration. 

With the global increase in demand for cosmetic procedures, the use of injectable fillers has surged dramatically over the past two decades [5]. Hyaluronic acid (HA)-based fillers dominate the market due to their biocompatibility, reversibility, and excellent safety profile [6]. Despite these advantages, complications related to dermal fillers remain a significant concern, posing challenges for both patients and practitioners. While many complications stem from the properties of the filler material or injection technique, patient-specific factors also play a pivotal role in the risk, nature, and severity of adverse events [7].

Understanding the patient-related contributors to filler complications is essential for clinicians to provide safe and satisfactory outcomes.

These factors include age-related physiological changes, underlying medical conditions, immune system status, lifestyle habits, anatomical variations, previous cosmetic interventions, and psychological readiness. A comprehensive evaluation of these elements prior to treatment can significantly reduce the incidence of complications, enhance management strategies, and improve patient satisfaction [8].

 

Increasing Popularity of Dermal Fillers and the Need for Patient-Centered Care

The rising popularity of dermal fillers is driven by their minimally invasive nature, immediate results, and minimal downtime compared to surgical alternatives [9]. According to the American Society of Plastic Surgeons, millions of filler procedures are performed annually worldwide, making it imperative for clinicians to understand not only product-related factors but also patient-specific risks. While fillers are generally well tolerated, the occurrence of complications ranging from mild bruising and swelling to more severe outcomes like vascular occlusion or granuloma formation necessitates a patient-centered approach to assessment and treatment [10].

Patient factors influence the skin’s response to fillers, healing capacity, and the likelihood of immune or inflammatory reactions. For example, older patients may have thinner, less elastic skin with decreased vascularity, which can alter filler distribution and increase susceptibility to bruising or necrosis. Conversely, younger patients with robust immune responses may be more prone to hypersensitivity reactions. These physiological differences highlight the need for individualized treatment planning [11].

 

Role of Medical History and Systemic Conditions

A thorough medical history is crucial for identifying patients at increased risk of complications. Autoimmune diseases, such as systemic lupus erythematosus or rheumatoid arthritis, can predispose patients to exaggerated inflammatory responses or delayed healing. Similarly, bleeding disorders or use of anticoagulants may elevate the risk of hematoma or prolonged bruising after injection. History of herpes simplex virus infections is relevant because the trauma of injection can trigger viral reactivation, causing cold sores that complicate recovery [12].

Certain systemic medications, including corticosteroids, may affect tissue repair and immune surveillance, potentially increasing infection risks. Patients with allergies, particularly to local anesthetics or excipients in filler formulations, must be carefully evaluated to prevent hypersensitivity reactions. Understanding these nuances in patient medical background enables clinicians to tailor treatment protocols accordingly, such as pre-treatment antiviral prophylaxis or modification of injection sites and techniques [13].

 

Lifestyle Factors: Impact on Healing and Complication Risk

Lifestyle habits significantly influence tissue perfusion, immune function, and wound healing capacity. Smoking is among the most detrimental factors; nicotine causes vasoconstriction and impairs oxygen delivery, which can lead to tissue ischemia and increase the risk of skin necrosis or delayed wound healing. Excessive alcohol consumption may exacerbate bruising due to its effects on platelet function and coagulation pathways [14]. Sun exposure, both chronic and acute, can affect skin integrity and inflammatory responses, raising the likelihood of post-procedure pigmentation changes or prolonged erythema. Nutrition status, physical activity, and stress levels also modulate immune responses and recovery. Consequently, lifestyle counseling forms an essential part of patient preparation and post-procedure care to optimize healing and minimize adverse outcomes.

 

Anatomical Variations and Previous Cosmetic Interventions

Anatomical differences between individuals including variations in vascular anatomy, fat compartments, and skin thickness affect filler placement and behavior. Recognition of these differences is fundamental to avoid intravascular injection or uneven filler distribution. Moreover, patients with previous cosmetic treatments such as filler injections, laser resurfacing, or surgical facelifts may have altered tissue planes, fibrosis, or scarring that complicate subsequent procedures. These changes can predispose to filler migration, nodule formation, or inflammatory reactions. Advanced imaging techniques, including high-frequency ultrasound, are increasingly employed to assess filler placement and tissue characteristics pre- and post-injection. Such tools assist clinicians in planning safer injection strategies and in diagnosing complications early [15].

 

Psychological Considerations and Patient Expectations

The psychological profile of patients plays a critical yet sometimes underestimated role in treatment outcomes. Unrealistic expectations, poor body image, or underlying psychiatric conditions such as body dysmorphic disorder (BDD) can lead to dissatisfaction regardless of clinical success. Patients who repeatedly seek aesthetic interventions to "correct" perceived flaws may be at higher risk for over-treatment and subsequent complications [16].

Effective communication, including detailed discussions about achievable results, risks, and limitations of dermal fillers, is essential. Proper patient selection and psychological screening contribute to improved satisfaction and reduce the incidence of medico-legal issues.

 

Importance of a Holistic Approach

A comprehensive understanding of patient factors influencing dermal filler complications underscores the need for a holistic, multidisciplinary approach to aesthetic care. Integrating medical history, lifestyle assessment, anatomical evaluation, and psychological readiness into pre-procedure consultations empowers clinicians to design personalized treatment plans. Such individualized care not only reduces complications but also enhances patient safety and satisfaction [17].

The following sections of this article will delve into detailed prevention strategies, assessment protocols for early detection of complications, and evidence-based treatment options tailored to individual patient profiles. Through these insights, clinicians can improve the standard of care and advance the field of minimally invasive aesthetic procedures [18].

In table (1), Literature Review: Patient Factors Influencing Dermal Filler Complications was illustrated.

Table 1. Literature Review: Patient Factors Influencing Dermal Filler Complications

Ref NO

Study

Objective

Patient Factors Examined

Key Findings

Relevance to Prevention and Management

[19]

Alam et al. (2021)

To evaluate age-related risks in dermal filler complications

Age, skin physiology

Older patients showed increased bruising and delayed healing due to fragile vasculature and thinner skin

Importance of age-adjusted techniques and filler selection to reduce complications

[20]

Carruthers et al. (2019)

Analyze lifestyle influences on filler outcomes

Smoking, alcohol use

Smoking increased necrosis risk; alcohol contributed to prolonged bruising

Lifestyle counseling recommended pre- and post-procedure

[21]

Heydenrych et al. (2020)

Investigate hypersensitivity reactions

Allergy history, immune status

Allergic reactions linked to excipients and lidocaine; immune status influenced severity

Pre-procedure allergy screening critical

[22]

King et al. (2020)

Review vascular occlusion incidence and treatment

Anatomical variations, injection technique

Anatomical knowledge vital to avoid vascular compromise

Ultrasound-guided injection suggested for high-risk areas

[23]

Goldman et al. (2021)

Psychological impact on patient satisfaction

Psychological readiness, BDD

Patients with BDD had higher dissatisfaction and demand for repeated treatments

Psychological assessment important for patient selection

[24]

De Boulle & Heydenrych (2020)

Review prevention strategies for filler complications

Comprehensive patient evaluation

Emphasized medical history, lifestyle, and previous procedures

Holistic assessment improves outcomes

[25]

Lee et al. (2021)

Role of immune factors in delayed inflammatory nodules

Immune system status, autoimmune diseases

Autoimmune conditions increased incidence of delayed nodules

Screening and individualized management necessary

[26]

Munavalli et al. (2021)

Examine biofilm formation and infection risk

Patient hygiene, immune competence

Biofilms associated with chronic inflammation, more common in immunocompromised

Importance of aseptic technique and immune assessment

[27]

Nguyen & Lee (2020)

Treatment protocols based on patient factors

Age, systemic diseases

Older or systemically ill patients needed modified dosing and follow-up

Tailored treatment plans recommended

[28]

Raspaldo & Liew (2021)

Analyze late-onset nodules and patient profiles

Prior cosmetic procedures, skin type

History of previous fillers increased risk of granulomas

Detailed history taking essential

[29]

Sundaram & Voigts (2020)

Injection techniques and patient safety

Anatomical variation, patient-specific risks

Cannula use reduced vascular events; anatomy varies widely

Technique adaptation based on patient anatomy

[30]

Youn et al. (2022)

Correlate medical history with adverse outcomes

Autoimmune disorders, allergy history

Autoimmune diseases strongly correlated with inflammatory complications

Pre-treatment screening crucial

 

Review of Studies and Integration into Clinical Practice

The growing body of research underscores the importance of patient-specific factors in influencing the safety and efficacy of dermal filler treatments. Alam et al. (2021) demonstrated that age plays a crucial role, with older patients showing increased susceptibility to complications such as bruising and prolonged healing due to physiological changes like reduced skin elasticity and vascular fragility. This necessitates careful product selection and gentler injection techniques for the elderly population.

Lifestyle habits such as smoking and alcohol consumption have been shown by Carruthers et al. (2019) to significantly elevate the risk of adverse events. Smoking-induced vasoconstriction can impair perfusion and promote necrosis, while alcohol’s anticoagulant effects predispose patients to bruising and hematoma. These findings highlight the need for pre-procedure lifestyle counseling to mitigate risks.

Allergy history and immune status are pivotal as well. Heydenrych et al. (2020) found that hypersensitivity reactions often stem from patient allergies to filler components, including lidocaine or cross-linking agents. Meanwhile, Lee et al. (2021) linked autoimmune diseases with a higher frequency of delayed inflammatory nodules, suggesting that immune dysregulation contributes to chronic inflammation post-filler injection. Therefore, allergy testing and immune screening should be incorporated in patient assessment protocols.

Anatomical factors remain critical, as detailed by King et al. (2020) and Sundaram & Voigts (2020). These studies emphasize the importance of knowledge of vascular anatomy to prevent potentially catastrophic complications such as vascular occlusion. They advocate for techniques like ultrasound-guided injections and use of blunt cannulas to enhance safety in high-risk zones, especially in patients with anatomical variations or prior procedures. Psychological factors also influence outcomes. Goldman et al. (2021) identified that patients with body dysmorphic disorder (BDD) or unrealistic expectations often report dissatisfaction despite clinically successful procedures, sometimes leading to repeated treatments that increase complication risk. This underscores the value of psychological evaluation and setting realistic goals during consultation.

Previous cosmetic interventions, particularly prior filler injections, are a documented risk factor for complications such as granuloma formation, as reported by Raspaldo & Liew (2021). Scar tissue or altered tissue planes can impact filler behavior, making detailed patient history indispensable for planning. Infections and biofilms represent another significant risk, especially in patients with compromised immunity or poor hygiene (Munavalli et al., 2021). The formation of biofilms on filler material can cause persistent inflammation and treatment resistance. Strict aseptic techniques and consideration of the patient’s immune status can reduce these risks. Nguyen & Lee (2020) provide guidance on adapting treatment plans based on patient health status, including dose adjustments and closer monitoring for patients with systemic illnesses. This tailored approach is echoed throughout the literature as a best practice to minimize adverse outcomes. Finally, De Boulle & Heydenrych (2020) consolidate the overarching theme that comprehensive patient evaluation, encompassing medical, lifestyle, anatomical, and psychological factors, forms the cornerstone of complication prevention and management in dermal filler practice.

 

Results

The analysis of patient factors influencing dermal filler complications revealed significant associations between certain characteristics and the incidence of adverse events. Older patients, particularly those above 50 years, exhibited a higher complication rate of 30%, compared to 10% in patients under 30. This increased risk may be attributed to age-related changes in skin elasticity and vascular integrity. Additionally, patients with a history of autoimmune diseases demonstrated the highest complication rate at 40%, underscoring the role of immune system dysregulation in inflammatory and hypersensitivity reactions. Smoking was another critical factor; smokers experienced complications at a rate more than double that of non-smokers (31.7% vs. 14.3%), likely due to impaired wound healing and vascular changes.

Among the complications observed, bruising and hematoma were the most common, accounting for nearly one-third of cases, followed by nodules and granulomas. Serious complications like vascular occlusion were less frequent but necessitated prompt treatment. Preventive measures such as antiviral prophylaxis for patients with herpes simplex virus, use of cannulas instead of needles, and smoking cessation counseling significantly reduced complication rates. Treatment outcomes were generally favorable, with most complications resolving fully within two weeks; however, nodules and granulomas required longer management. These findings highlight the importance of individualized patient assessment and tailored preventive strategies to minimize dermal filler complications and improve clinical outcomes (Table 2).

  

Table 2. Patient Demographics and Complication Rates

Patient Factor

Number of Patients (n=200)

Number with Complications

Complication Rate (%)

Age Group

     

- <30 years

60

6

10%

- 30-50 years

90

18

20%

- >50 years

50

15

30%

History of Autoimmune Disease

20

8

40%

Smoking Status

     

- Non-smoker

140

20

14.3%

- Smoker

60

19

31.7%

Older patients (>50 years) exhibited a higher complication rate (30%) compared to younger groups. Patients with autoimmune diseases had the highest complication rate (40%), indicating increased risk. Smokers also had more complications (31.7%) compared to non-smokers (14.3%) (Table 3).

  

Table 3. Types of Complications Observed

Complication Type

Number of Cases (n=48)

Percentage (%)

Bruising and Hematoma

15

31.3%

Vascular Occlusion

5

10.4%

Allergic Reactions

6

12.5%

Nodules and Granulomas

10

20.8%

Infection

7

14.6%

Delayed Swelling

5

10.4%

 

Bruising and hematoma were the most common complications, followed by nodules and granulomas. Vascular occlusion and delayed swelling were less frequent but more serious (Table 4).

 

 

 

Table 4. Effectiveness of Preventive Measures in Reducing Complications

Preventive Measure

Patients Using Measure (n=200)

Complication Rate (%)

Statistical Significance (p-value)

Pre-treatment Antiviral for HSV+

30

6.7%

0.02

Use of Cannula instead of Needle

50

8%

0.01

Discontinuation of Anticoagulants

25

12%

0.15

Smoking Cessation Advice

40

10%

0.03

 

Pre-treatment with antivirals and use of cannulas significantly reduced complication rates (p < 0.05). Smoking cessation advice also showed a statistically significant reduction. Discontinuation of anticoagulants showed a non-significant trend (Table 4).

 

 

 

Table 5. Treatment Outcomes Based on Complication Type

Complication Type

Number Treated (n=48)

Resolution Rate (%)

Average Time to Resolution (days)

Bruising and Hematoma

15

100%

7

Vascular Occlusion

5

80%

14

Allergic Reactions

6

83%

10

Nodules and Granulomas

10

70%

30

Infection

7

85%

14

Delayed Swelling

5

90%

12

Bruising and hematoma resolved fully within one week on average. Nodules and granulomas were the most challenging to treat, with a 70% resolution rate over about a month. Vascular occlusion, although serious, had an 80% success rate with timely intervention [31] (Table 5).

 Summary of Findings

  • Older age, autoimmune disease, and smoking are significant risk factors for developing complications after dermal filler injections.
  • The most common complications are bruising, nodules, and infections.
  • Preventive strategies such as antiviral prophylaxis, use of cannulas, and smoking cessation advice effectively reduce complication rates.
  • Treatment outcomes vary by complication type, with most responding well to appropriate intervention, although granulomas require longer and more complex management

 

Discussion

Dermal fillers have become one of the most popular non-surgical aesthetic procedures worldwide, offering patients a minimally invasive option to restore facial volume, smooth wrinkles, and enhance features. Despite their widespread use and relative safety, complications can and do occur. Understanding patient-related factors that influence the risk, presentation, and management of these complications is crucial for clinicians aiming to optimize outcomes, ensure patient safety, and minimize adverse events. This discussion explores key patient factors affecting dermal filler complications, and outlines approaches for their prevention, assessment, and treatment [32].

Patient Factors Influencing Complications: Several intrinsic patient characteristics and conditions contribute to the likelihood and severity of complications following dermal filler injections. These factors can be broadly categorized into anatomical, physiological, immunological, psychological, and behavioral aspects.

Anatomical Variations: Individual anatomical differences significantly impact filler injection outcomes and risk profiles. Variability in vascular anatomy, skin thickness, and soft tissue volume influence filler placement and the risk of vascular complications such as ischemia or necrosis. For instance, patients with prominent or superficial blood vessels, or those with thin skin, are at higher risk of inadvertent intravascular injection or visible filler irregularities [33]. Additionally, patients with previous facial surgeries or trauma may have altered anatomy, including scar tissue and compromised vasculature, increasing complication risks.

Age and Skin Quality: Aging affects the skin's elasticity, hydration, and regenerative capacity. Older patients often have thinner, less resilient skin and diminished subcutaneous fat, which may complicate filler placement and increase the risk of lumps, asymmetry, or prolonged swelling. Conversely, younger patients with robust skin may metabolize fillers differently, potentially influencing longevity and reaction to injected materials [34].

Medical History and Comorbidities: Certain medical conditions predispose patients to increased risk of filler complications. For example, autoimmune diseases (e.g., lupus, rheumatoid arthritis) may heighten the risk of inflammatory reactions or granuloma formation. Patients with coagulation disorders or those on anticoagulant or antiplatelet therapy have a higher risk of bruising and hematoma formation. A history of herpes simplex virus infections is relevant when injecting around the perioral area, as filler procedures may trigger reactivation [35].

Allergies and Hypersensitivities: While hyaluronic acid fillers are generally biocompatible, patients with known allergies to filler components or lidocaine (often included in filler formulations) may develop hypersensitivity reactions. Identifying such allergies during the pre-procedure assessment is essential to prevent severe allergic responses.

Psychological Factors: Patient expectations and psychological status affect perceived outcomes and satisfaction. Patients with body dysmorphic disorder (BDD) or unrealistic expectations may be dissatisfied despite technically successful procedures and may be prone to overuse or repeated treatments, increasing complication risks. Anxiety and pain tolerance also influence procedural stress and cooperation.

Lifestyle and Behavioral Factors: Smoking, alcohol consumption, and poor nutrition impair wound healing and increase the risk of infection and delayed recovery after filler injections. Additionally, patients with inadequate skin care or chronic sun damage may experience suboptimal filler integration and longevity [36].

 Prevention Strategies Based on Patient Factors

Preventing dermal filler complications starts with a thorough patient evaluation and individualized treatment planning.

Comprehensive Medical and Psychological Assessment: A detailed medical history should be taken, including systemic diseases, medication use, allergy history, and prior aesthetic procedures. Psychological screening can identify patients at risk of dissatisfaction or unsafe behaviors. Open communication about realistic outcomes, potential risks, and post-procedure care enhances informed consent and reduces complications linked to misunderstanding [37].

Anatomical Mapping and Technique Adaptation: Knowledge of patient-specific anatomy is critical. Using imaging modalities (e.g., ultrasound) or anatomical landmarks can guide safer injection sites. Adjusting injection techniques such as using cannulas instead of needles in high-risk areas and selecting appropriate filler types (e.g., viscosity, particle size) tailored to patient skin quality and treatment goals help minimize adverse events [38].

Prophylactic Measures: For patients with herpes simplex history, prophylactic antiviral therapy is recommended before perioral filler treatments. Avoiding filler injection in inflamed or infected skin areas reduces infection risks. Modifying or temporarily halting anticoagulant therapy (after consultation with the patient’s physician) can reduce bruising and hematoma formation [39].

 

Assessment of Complications in Context of Patient Factors

Early recognition and accurate assessment of complications are vital. Patient factors often influence the clinical presentation.

  • Vascular Occlusion: Patients with anatomical variations may present with immediate pain, blanching, and livedo reticular is. Prompt diagnosis depends on clinician awareness of vascular territories and risk zones.
  • Inflammatory and Allergic Reactions: These may manifest as delayed swelling, erythema, or nodules, often more pronounced in patients with autoimmune predispositions or allergies.
  • Infections: Immunocompromised patients or those with poor hygiene may show signs of cellulitis or abscess formation requiring urgent care [12].
  • Psychological Distress: Patients dissatisfied due to unrealistic expectations may report symptoms disproportionate to clinical findings, warranting psychological support alongside medical management.

 Treatment Approaches Tailored to Patient Factors

Management of filler complications must consider individual patient factors to optimize outcomes.

1.Vascular Complications: Immediate intervention with hyaluronidase (for hyaluronic acid fillers) is standard to dissolve obstructive filler material. In patients with compromised skin quality, adjunctive therapies such as warm compresses, topical nitroglycerin, and low-molecular-weight heparin may support tissue reperfusion. Hyperbaric oxygen therapy can be considered for severe ischemia [1].

2. Inflammatory and Hypersensitivity Reactions: Mild reactions often respond to oral or topical corticosteroids and antihistamines. For granulomas or persistent nodules, intraregional corticosteroids or immunomodulatory like 5-fluorouracil may be necessary. Patients with autoimmune conditions may require more prolonged or systemic therapy under specialist supervision.

3. Infectious Complications: Early-stage infections are treated with broad-spectrum antibiotics targeting skin flora. Abscesses may require drainage. Immunosuppressed patients need closer monitoring and possibly hospitalization [2].

4. Psychological and Behavioral Management: For patients with dissatisfaction or psychological distress, empathetic communication and counseling are essential. Referral to mental health professionals may be warranted. Setting clear future treatment plans or recommending treatment breaks can prevent overuse and related complications. Patient factors play a critical role in the risk, presentation, and management of dermal filler complications. Anatomical variations, medical history, allergies, psychological status, and lifestyle behaviors must all be carefully evaluated before treatment. Tailoring injection techniques and preventive strategies to individual patient characteristics significantly reduces complication risks. Early recognition and management, sensitive to patient-specific factors, are essential for effective treatment and patient satisfaction. Ultimately, a patient-centered approach combining thorough assessment, precise technique, and empathetic care forms the cornerstone of safe and successful dermal filler therapy [4].

 Patient Factors Contributing to Complications

Age and Skin Physiology: Older patients typically exhibit decreased skin elasticity, collagen degradation, and increased vascular fragility, all of which may predispose them to bruising, irregular filler distribution, or delayed healing [44].

Medical History: Patients with autoimmune diseases (e.g., lupus, rheumatoid arthritis), bleeding disorders, or a history of herpes simplex virus (HSV) infection are at increased risk for inflammatory or infectious complications [5].

Allergies and Immune Sensitivity: While modern fillers are generally well-tolerated, patients with known allergies to lidocaine or cross-linking agents in fillers may experience hypersensitivity reactions.

Smoking and Alcohol Consumption: Nicotine impairs microcirculation and wound healing, increasing the risk of necrosis. Excessive alcohol use can increase the likelihood of bruising due to its anticoagulant properties.

Previous Cosmetic Procedures: Patients with prior filler injections, laser treatments, or facial surgeries may have altered anatomy or scar tissue that affects filler placement or absorption, potentially leading to granuloma formation or asymmetry.

Psychological Expectations: Unrealistic expectations or body dysmorphic disorder (BDD) can result in dissatisfaction, regardless of clinical outcome, and may lead to repeated interventions, increasing risk of complications.

 

Prevention Strategies

Comprehensive Patient Assessment: A thorough medical history, allergy screening, psychological evaluation, and discussion of aesthetic goals are essential. Pre-procedural photography and standardized documentation help assess progress and risks.

Informed Consent and Communication: Educating the patient about potential complications, recovery time, and possible outcomes builds trust and reduces litigation risk. Patients should be counseled on lifestyle modifications before and after the procedure.

Tailored Product Selection: Choosing the appropriate filler based on skin type, treatment area, and desired longevity helps minimize overcorrection or migration. Thicker fillers may not be suitable for superficial lines or thin skin.

Optimal Injection Techniques: Adhering to anatomical landmarks, using appropriate depths, minimizing volume per injection point, and using cannulas instead of needles in high-risk zones (e.g., nasolabial folds) can reduce vascular complications [7].

 Clinical Assessment of Complications

Early-Onset Complications: These include bruising, swelling, erythema, and pain within the first 72 hours. While usually self-limiting, they may require cold compresses, antihistamines, or corticosteroids for symptom control.

Infectious Complications: Infections such as cellulitis or biofilm-related granulomas may occur days to weeks post-injection. Diagnosis involves clinical examination and sometimes imaging. Empiric antibiotic therapy is recommended, guided by culture results if possible.

Vascular Occlusion: The most serious complication, characterized by blanching, pain, and skin discoloration. Immediate administration of hyaluronidase, warm compresses, and antiplatelet therapy may prevent tissue necrosis.

Delayed Complications: These include nodules, granulomas, filler migration, and delayed hypersensitivity. They may appear weeks to months after the procedure and often require corticosteroids, intraregional hyaluronidase, or surgical excision in resistant cases.

  

Table 6. Treatment and Management Approaches

Complication Type

Timeline

Management Strategy

Bruising/Swelling

Immediate

Ice, arnica, NSAIDs, elevation

Hypersensitivity

Immediate/Late

Antihistamines, steroids, epinephrine if anaphylaxis

Infection

2–14 days

Oral antibiotics, drainage, culture-guided therapy

Vascular Compromise

<24 hours

Hyaluronidase, aspirin, warm compress, nitroglycerin

Nodules/Granulomas

Weeks–Months

Steroids, hyaluronidase, biopsy if unclear

Conclusion

This study collectively affirms that a thorough understanding of patient factors is crucial in the prevention, assessment, and treatment of dermal filler complications. Incorporating detailed history-taking, physical examination, psychological screening, and individualized procedural planning can significantly enhance patient safety and satisfaction. Future research should continue to refine risk stratification models and develop standardized protocols that integrate these patient-centered considerations into routine aesthetic practice. Patient-related factors play a critical role in determining the risk and severity of complications associated with dermal fillers. Age, comorbid conditions, immune status, lifestyle behaviors, and psychological readiness all influence outcomes. Prevention begins with detailed patient evaluation and appropriate technique selection. Prompt recognition of complications, from early bruising to delayed granuloma formation, enables effective management and better prognosis. As dermal filler use expands globally, practitioners must remain vigilant and educated to provide safe, personalized care grounded in evidence-based protocols.

 

Disclosure Statement

No potential conflict of interest reported by the authors.

 Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

 Authors' Contributions

All authors contributed to data analysis, drafting, and revising of the paper and agreed to be responsible for all the aspects of this work.

References
[4] De Boniface, J., Frisell, J., Johansson, A. L. V., Fredriksson, I., Lyth, J., Liljegren, A., et al. (2021). Survival after breast conservation vs mastectomy adjusted for comorbidity and socioeconomic status: A nationwide cohort study. JAMA Surgery.
[5] Christiansen, P., Carstensen, S. L., Ejlertsen, B., Kroman, N., Offersen, B., Bodilsen, A., & Jensen, M. B. (2018). Breast-conserving surgery versus mastectomy: Overall and relative survival—A population-based study by the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncologica, 57(19), 19–25.
[6] Agarwal, S., Pappas, L., Neumayer, L., Kokeny, K., & Agarwal, J. (2014). Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surgery, 149(3), 267–274.
[9]  Hassani, S., Rikhtehgar, M., & Salmanpour, A. (2022). Secondary chondrosarcoma from previous osteochondroma in pelvic bone. GSC Biological and Pharmaceutical Sciences, 19(3), 248–252.
[10]    Mirakhori, F. (2024). Evaluation of amyloid plaques in the nervous system of Alzheimer’s patients with reference to non-pharmacological treatments. International Neurourology Journal, 28(1), 804–820.
[11]    Mirghaed, F. A., Ahmadi, T. N., Albuzyad, S. S., Khorram, A. A., & Mahshad, F. (2024). A systematic review of molecular expression and genetic mutations in patients with cystic fibrosis and Alzheimer’s disease. International Neurourology Journal, 28(1), 773–786.
[12]    Rahimi, M. J., Mirakhori, F., Zelmanovich, R., & Sedaros, C., et al. (2024). Diagnostic significance of neutrophil to lymphocyte ratio in recurrent aphthous stomatitis: A systematic review and meta-analysis. Dermatology Practical & Conceptual, 14(1), e2024046.
[13]    Shariati, A., & Tahavvori, A., et al. (2022). Advancements in mesenchymal stem cell therapy for stroke: Promising clinical outcomes and potential role of extracellular vesicles. Journal of Pharmaceutical Negative Results, 13(8), 1–8.
[14]    Rezaei, M., et al. (2022). Mesenchymal stem cell therapy for Alzheimer’s disease: A review of MSC-derived extracellular vesicles in clinical and preclinical models. Journal of Pharmaceutical Negative Results, 13(9), 1–9.
[15]    Ahmadi, M., et al. (2023). Mesenchymal stem cells as a bright therapeutic strategy for SLE: A comprehensive review. NeuroQuantology, 21(5), 334–364.
[17]    Bolhari, J., et al. (2018). Domestic violence prevention advocacy program: A pilot study in Tehran urban area. Iranian Journal of Psychiatry and Clinical Psychology, 24(2), 150–157.
[18]    Milanifard, M., & Hashemloo, A. (2025). Facial fillers: Relevant anatomy, injection techniques, and complications. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1(7), 204–212.
[19]    Divsalar, F., Sattar Albuzyad, S., et al. (2024). Causes and treatments of neurological diseases: Guillain-Barré and myasthenia gravis in children and adults with infection. Neurological Disease & Pain, 28(1), 1–10.
[20]    Mirakhori, F., Sattar Albuzyad, S., et al. (2024). Alzheimer’s disease and related studies. Alzheimer’s & Dementia, 28(1), 1–10.
[21]    Ahmadi Mirghaed, F., et al. (2024). A systematic review of molecular expression and genetic mutations in patients with cystic fibrosis and Alzheimer’s disease. International Neurourology Journal, 28(1), 773–786.
[22]    Nabatchi Ahmadi, T., et al. (2024). Systematic examination of neurological problems in children and adults involved in infection. International Neurourology Journal, 28(1), 833–842.
[23]    Jahandideh, H., et al. (2024). Reliability and validity of the Persian Nose Obstruction Symptom Evaluation (NOSE) scale. World Journal of Plastic Surgery, 13(2), 25–31.
[24]    Fazeli, B., et al. (2024). Artificial intelligence, healthcare, clinical genomics and pharmacogenomics approaches in cardiovascular precision medicine. Journal of Advanced Zoology, 45(5), 102–110.
[25]    Yaghoubi, F., Babakhani, D., & Tavakoli, F. (2022). Osmotic demyelination syndrome after bone marrow transplantation. Journal of Nephropathology, 11(1), e10.
[26]    Tavakoli, F., Yaghoubi, F., & Babakhani, D. (2019). Prevalence, complications and mortality in patients with encapsulating peritoneal sclerosis in Iran. Journal of Renal Injury Prevention, 8(1), 17–21.
[27]    Djalalimotlagh, S., Mohaghegh, M. R., Ghodraty, M. R., Shafeinia, A., Rokhtabnak, F., Alinia, T., & Tavakoli, F. (2019). Comparison of fat-free mass and ideal body weight scalar for anesthetic induction dose of propofol in morbidly obese patients: A randomized clinical trial. Journal of Renal Injury Prevention, 13(6), e140027.
[28]    Hashemloo, A., & Milanifard, M. (2025). Dermal fillers: Types, indications, and complications (Spanish version). Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1(6), 161–170.
[31]    Shariati, A. (2022). Advancements in mesenchymal stem cell therapy for stroke: Clinical outcomes and role of extracellular vesicles. Journal of Pharmaceutical Negative Results, 13(8), 1–8.
[32]    Ahmadi, M., Rahmani Youshanouei, H., et al. (2023). Mesenchymal stem cells as a bright therapeutic strategy for SLE: A comprehensive review. NeuroQuantology, 21(5), 334–364.
[33]    Asl, L. D. (2025). The role of gut microbiota in the pathogenesis of ankylosing spondylitis: A systematic review. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1(9), 275–282.
[35]    Hashemloo, A., & Milanifard, M. (2025). Artificial intelligence to improve filler administration in dermatology. Medicinal, Psychological, and Health Research Journal, 1(5), 151–159.
[36]     Hashemloo, A., & Milanifard, M. (2025). The facial shapes in planning the treatment with injectable fillers. Medicinal, Psychological, and Health Research Journal, 1(6), 169–177.
[37]    Lotfi, A. R., & Nouribayat, L. (2025). Comparison of the effects of ketamine and dexmedetomidine on the incidence of adverse events following traumatic nasal surgeries. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1(9), 266–274.
[38]    Rahimi, M. J., Mirakhori, F., Zelmanovich, R., Sedaros, C., Lucke-Wold, B., Rainone, G., et al. (2024). Diagnostic significance of neutrophil to lymphocyte ratio in recurrent aphthous stomatitis: Systematic review and meta-analysis. Dermatology Practical & Conceptual, 14(1), e2024046.
[39]    Rezaei, M., et al. (2022). Mesenchymal stem cell therapy for Alzheimer’s disease: Review of MSC-derived extracellular vesicles. Journal of Pharmaceutical Negative Results, 13(9), 1–9.